Accessibility Menu

Bioventix Plc

(LSE) BVXP

Current Price£15.80
Market Cap£83.60MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2010)+1,594%
5 Year-59%
1 Year-41%
1 Month+0%

Bioventix Plc Financials at a Glance

Market Cap

£83.60MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£26.21M

Net Income (TTM)

£15.28M

EPS (TTM)

£1.41

P/E Ratio

11.24

Dividend

£1.50

Beta (Volatility)

0.01 (Low)

Price

£15.80

Volume

815

Open

£15.90

Previous Close

£15.82

Daily Range

£15.80 - £15.90

52-Week Range

£13.20 - £28.60

Estimated Earnings Date

Oct 26, 2026

BVXP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bioventix Plc

Industry

Biotechnology

CEO

Peter J. Harrison

Headquarters

Farnham, SU W1W 8DH, GB

BVXP Financials

Key Financial Metrics (TTM)

Gross Margin

91.93%

Operating Margin

75.62%

Net Income Margin

59.30%

Return on Equity

65.83%

Return on Capital

85.73%

Return on Assets

57.06%

Earnings Yield

8.90%

Dividend Yield

9.37%

Payout Ratio

1.05%

Stock Overview

Market Cap

£83.60MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

5.22M

Volume

815

Avg. Volume

8.28K

Financials (TTM)

Gross Profit

£23.85M

Operating Income

£19.79M

EBITDA

£19.88M

Operating Cash Flow

£15.71M

Capital Expenditure

-£62.53K

Free Cash Flow

£15.65M

Cash & ST Invst.

£5.30M

Total Debt

£0.00

Bioventix Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

£6.16M

-7.7%

Gross Profit

£5.62M

-9.7%

Gross Margin

91.24%

N/A

Market Cap

£83.60MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

£4.92M

N/A

Employees

17

N/A

Net Income

£3.63M

-9.9%

EBITDA

£4.59M

-12.0%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Total Cash

£5.30M

-3.7%

Total Debt

£0.00

N/A

Accounts Receivable

£6.17M

+4.1%

Inventory

£723.30K

+23.5%

Long Term Debt

£0.00

N/A

Short Term Debt

£0.00

N/A

Return on Assets

57.06%

N/A

Return on Invested Capital

85.90%

N/A

Free Cash Flow

£4.40M

+0.2%

Operating Cash Flow

£4.44M

+0.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EKF.LEKF Diagnostics Holdings plc
£0.25-2.34%
HEMO.LHemogenyx Pharmaceuticals Plc
£8.20+5.81%
HVO.LhVIVO plc
£0.07-1.07%
DXRX.LDiaceutics PLC
£1.44+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
AAPLApple
$316.06+0.01%
OPENOpendoor Technologies
$5.31+0.11%
JLHLJulong
$12.79+3.18%
TQQQProShares Trust - ProShares UltraPro Qqq
$76.34+0.05%

Questions About BVXP

What is the current price of Bioventix Plc?

Bioventix Plc is trading at £15.80 per share.

What is the 52-week range for Bioventix Plc?

Over the past 52 weeks, Bioventix Plc has traded between £13.20 and £28.60.

How much debt does Bioventix Plc have?

As of the most recent reporting period, Bioventix Plc reported total debt of £0.00.

How much cash does Bioventix Plc have on hand?

Bioventix Plc reported £5.08M in cash and cash equivalents in its most recent financial results.

What is Bioventix Plc’s dividend yield?

Bioventix Plc currently has a dividend yield of 9.37%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.